{
    "id": 26090,
    "fullName": "AFF3 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "AFF3 positive indicates the presence of the AFF3 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3899,
        "geneSymbol": "AFF3",
        "terms": [
            "AFF3",
            "LAF4",
            "MLLT2-like"
        ]
    },
    "variant": "positive",
    "createDate": "03/01/2017",
    "updateDate": "03/01/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10113,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, decreased expression of AFF3 via shRNA in an adrenocortical carcinoma cell line resulted in increased apoptotic activity, decreased cell proliferation, and a reduction in the rate of colony formation, suggesting AFF3 may serve as a future therapeutic target (PMID: 26214578).",
            "molecularProfile": {
                "id": 27258,
                "profileName": "AFF3 positive"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 3948,
                "name": "adrenocortical carcinoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 8031,
                    "pubMedId": 26214578,
                    "title": "Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of \u03b2-catenin in adrenocortical carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26214578"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27258,
            "profileName": "AFF3 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}